Drug screening tests support to analyze and diagnose biological samples like blood, hair, and urine and detect the presence of drugs of abuse or its metabolites in the body of patients. These tests are shown in order to ascertain if a person is or was under the influence of a drug at a certain point in time. Technological advancements in drug screening devices have allowed end-users to acquire accurate results. In emerging economies like China, rising incidences of drug abuse amongst adults as well as the teenage population have hampered employment impeding the economic situation of the country proving to be the main factor contributing to industry growth. Similarly, government bodies and not-for-profit organizations focus their efforts on funding drug screening initiatives thereby augmenting drug screening practices. Although this industry has a high growth rate, certain social and political decisions may restrict market development. For instance, political decisions such as the ban on alcohol consumptions in certain countries can have a negative impact in the near future. The global market is segregated on the basis of Sample Type as Oral Fluid, Hair, Urine, Breath, and Other Samples. Based on Products & Services the global market is segmented in Drug Screening Services and Drug Screening Products. Based on End User the global market is segmented in Pain Management Centers, Schools and Colleges, Hospitals, Individual users, Workplace, Criminal Justice Systems and Law Enforcement Agencies, and Drug Treatment Centers.

The global market report provides geographical analysis covering regions, such as North America, Europe, Asia-Pacific, and the Rest of the World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Alere (US), Thermo Fisher (US), Drägerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US), and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

The global Drug Screening market has been segmented as below:

By Sample Type

• Oral Fluid
• Hair
• Urine
• Breath
• Other Samples

By Products & Services

• Drug Screening Services
• Drug Screening Products
  • Consumables
  • Rapid Testing Devices
  • Analytical Instruments

By End-User

• Pain Management Centers
• Schools and Colleges
• Hospitals
• Individual users
• Workplace
• Criminal Justice Systems and Law Enforcement Agencies
• Drug Treatment Centers

By Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

By Company

• Alere (US)
• Thermo Fisher (US)
• Drägerwerk (Germany)
• OraSure (US)
• Alfa Scientific Designs (US)
• Lifeloc (US)
• MPD, Inc. (US)
• Premier Biotech (US)
• Shimadzu (Japan)
• Siemens Healthineers (US)
• LabCorp (US)
• Quest Diagnostics (US)
• Omega Laboratories (US)
• Psychemedics (US)
• CRL (US)
• SureHire (Canada)
• CannAmm (Canada)

The report covers the below scope:

• Global market sizes from 2019 to 2025, along with CAGR for 2019-2025
• Market size comparison for 2019 vs 2025, with actual data for 2019, estimates for 2020 and forecast from 2021 to 2025
• Global market trends, covering a comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
• Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

• Base year - 2019
• Estimated year - 2020
• Projected year - 2021
• Forecast period - 2021 to 2025

Report Scope:

The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Alere (US), Thermo Fisher (US), Drägerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US), and others.

Why Buy this Report:

• Gain detailed insights on the Drug Screening industry trends
• Find a complete analysis of the market status
• Identify the market opportunities and growth segments
• Analyze competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

The report targeted the existing players in the industry is as follows:

• Market Manufacturers/Service Providers
• Market Wholesale/Traders
• Investment and Financial Institutions

Free and Paid Customization based on the requirement